Abuse Deterrence
Building Guardrails, Not Just Pills: Rethinking Pain Management without Abuse
David Alvaro, Ph.D.; Paul Howe
Pharma's Almanac
PAO-06-25-CL-11Jun 24, 2025
Opioid
Trevena Announces FDA Approval of OLINVYK Injection
Trevena
PR-M08-20-NI-30Aug 18, 2020
Opioid Disorder
Braeburn Submits Request for Final Approval of BRIXADI for the Treatment of Opioid Use Disorder
Braeburn
PR-M06-20-NI-014Jun 11, 2020
Opioid Crisis
J&J Awaits Judge’s Decision in Lawsuit Filed by Oklahoma Over the Opioid Crisis
Nice Insight
PAO-M07-19-NI-021Jul 22, 2019
Opioid Abuse
Opioid Abuse is Linked to a Rise in Infectious Diseases
Emilie Branch
Pharma's Almanac
PAO-M07-19-NI-016Jul 10, 2019
Opioid Crisis
Analysis of Medicare Prescriptions Uncovers Role Surgeons Played in Opioid Crisis
Nice Insight
PAO-M07-19-NI-002Jul 01, 2019
Opioid Crisis
Oklahoma vs. Johnson & Johnson Opioid Crisis Trial
Nice Insight
PAO-M06-19-NI-006Jun 13, 2019
Pain Treatment
Eli Lilly Acquires Rights to Non-Opioid Pain Treatment
Nice Insight
PAO-M05-19-NI-038May 31, 2019
Generic
First Generic Nalaxone Nasal Spray Approved by FDA
Emilie Branch
Pharma's Almanac
PAO-M05-19-NI-006May 02, 2019
Opioid Treatment
Failed Depression Drug Could be Opioid Addiction Treatment
Emilie Branch
Pharma's Almanac
PAO-M04-19-NI-012Apr 10, 2019
New Approvals Allow Chronic Pain Sufferers to Try Abbott's Non-Opioid Pain Therapy Before Getting Device Implant
Abbott
PA3370Nov 20, 2018
Opioids
Proposed Opioid Bill Includes New Payment Disclosures
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M10-18-NI-007Oct 04, 2018
FDA Approval
Dr. Reddy's Laboratories announces USFDA final approval and launch of Buprenorphine and Naloxone Sublingual Film in the U.S. Market
Dr. Reddy's Laboratories
PR-M06-18-NI-063-4098Jun 19, 2018
Clinical Data
New Data for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Low Back Pain in Adult Patients New to Opioid Therapy
Nektar Therapeutics
PR-M06-18-NI-058Jun 18, 2018
FDA Approval
New Treatment for Management of Opioid Withdrawal Symptoms Approved by FDA
Emilie Branch
Pharma's Almanac
PAO-M05-18-NI-019May 24, 2018
FDA Approval
FDA approves the first non-opioid treatment for management of opioid withdrawal symptoms in adults
U.S. Food & Drug Administration
PR-M05-18-NI-079May 21, 2018